Syneos Health Appoints William E. Klitgaard Independent Director
October 14, 2022 16:45 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of William E....
Syneos Health Wins Triangle Business Journal 2022 Leaders in Diversity Award
October 13, 2022 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has been awarded a Triangle...
Syneos Health Expands Partnership with Datavant to Accelerate Delivery of New Therapies to Patients
October 11, 2022 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced an expanded partnership with...
Syneos Health Releases Annual Sustainability Report
October 05, 2022 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 2021 Sustainability Report....
Syneos Health to Present at the 2022 Baird Global Healthcare Conference
August 30, 2022 17:20 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...
Syneos Health Reports Second Quarter 2022 Results
August 02, 2022 06:05 ET
|
Syneos Health, Inc.
Revenue for the second quarter of $1,360.7 million increased 6.1% on a reported basis and 8.3% on a constant currency basis year-over-year.Clinical Solutions net new business awards and book-to-bill...
Syneos Health Schedules Second Quarter 2022 Earnings Call for Tuesday, August 2, 2022
July 18, 2022 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., July 18, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its second quarter 2022 financial...
Syneos Health to Present at Upcoming Investor Conferences
May 24, 2022 07:01 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 24, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced that the Company is scheduled to...
Syneos Health Leaders Recognized by HBA
May 10, 2022 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Kasey Boynton, MPH, MBA,...
Syneos Health Names Michelle Keefe as Next Chief Executive Officer
April 29, 2022 06:26 ET
|
Syneos Health, Inc.
Alistair Macdonald to Retire After 20 Years in Variety of Leadership Roles Michael Brooks Named Chief Operating Officer Company Reports First Quarter 2022 Results and Updates Full Year Guidance ...